Oncofid-P-B (paclitaxel-hyaluronic acid) in the intravesical therapy of patients affected by primary or recurrent Ta G1-G2 papillary cancer of the bladder. A phase II marker lesion study
| Autor: | C. Llorente, G. Nohales Taurines, J. Moreno Sierra, Cesare Selli, Michele Battaglia, A. Neisius, Marco Racioppi, A. Marinello, Paolo Gontero, N. Giordan, G. Palermo, M.F. Arjona, Pierfrancesco Bassi, F. Vom Dorp, Claudio Simeone, D. Castro Diaz, A. Eisendhardt, M. Ramirez Backhaus |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
medicine.medical_specialty
business.industry Urology Lesion study Cancer 02 engineering and technology 010402 general chemistry 021001 nanoscience & nanotechnology medicine.disease 01 natural sciences 0104 chemical sciences chemistry.chemical_compound chemistry Paclitaxel Hyaluronic acid medicine 0210 nano-technology business |
| Zdroj: | European Urology Supplements. 17:e1056-e1057 |
| ISSN: | 1569-9056 |
| DOI: | 10.1016/s1569-9056(18)31567-7 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect